Trexquant Investment’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Buy |
258,937
+43,571
| +20% | +$355K | 0.02% | 871 |
|
|
2025
Q1 | $1.69M | Sell |
215,366
-85,182
| -28% | -$669K | 0.02% | 919 |
|
|
2024
Q4 | $4.48M | Buy |
300,548
+212,552
| +242% | +$3.16M | 0.05% | 561 |
|
|
2024
Q3 | $1.35M | Sell |
87,996
-164,590
| -65% | -$2.52M | 0.02% | 945 |
|
|
2024
Q2 | $3.85M | Buy |
252,586
+214,469
| +563% | +$3.27M | 0.06% | 489 |
|
|
2024
Q1 | $720K | Sell |
38,117
-5,420
| -12% | -$102K | 0.01% | 1039 |
|
|
2023
Q4 | $832K | Sell |
43,537
-35,100
| -45% | -$670K | 0.02% | 889 |
|
|
2023
Q3 | $1.41M | Buy |
+78,637
| New | +$1.41M | 0.04% | 617 |
|
|
2023
Q2 | – | Sell |
-18,827
| Closed | -$343K | – | 1740 |
|
|
2023
Q1 | $343K | Sell |
18,827
-6,244
| -25% | -$114K | 0.01% | 1145 |
|
|
2022
Q4 | $518K | Buy |
+25,071
| New | +$518K | 0.01% | 902 |
|
|
2022
Q3 | – | Sell |
-8,190
| Closed | -$208K | – | 1767 |
|
|
2022
Q2 | $208K | Buy |
+8,190
| New | +$208K | 0.01% | 1334 |
|
|
2021
Q2 | – | Sell |
-7,189
| Closed | -$202K | – | 1436 |
|
|
2021
Q1 | $202K | Sell |
7,189
-6,236
| -46% | -$175K | 0.02% | 963 |
|
|
2020
Q4 | $349K | Sell |
13,425
-39,251
| -75% | -$1.02M | 0.04% | 606 |
|
|
2020
Q3 | $903K | Buy |
52,676
+23,327
| +79% | +$400K | 0.06% | 454 |
|
|
2020
Q2 | $726K | Buy |
29,349
+3,040
| +12% | +$75.2K | 0.05% | 524 |
|
|
2020
Q1 | $365K | Buy |
+26,309
| New | +$365K | 0.03% | 778 |
|
|
2019
Q2 | – | Sell |
-16,361
| Closed | -$204K | – | 1066 |
|
|
2019
Q1 | $204K | Buy |
+16,361
| New | +$204K | 0.01% | 864 |
|